Sponsored Projects Administration is fully functional and operating at normal capacity even though the University has suspended on-site operations for purposes of decreasing COVID-19 transmission.
Information and Resources for Researchers:
HHS/Biomedical Advanced Research and Development Authority (BARDA)
BARDA opened an easy broad agency announcement, an EZ-BAA, seeking diagnostics that utilize platforms already cleared by the FDA, with a viable plan to meet requirements for the FDA to consider emergency use authorization within 12 weeks.
Administrative Supplementals Current grantees may be eligible to apply for an administrative supplemental. Contact your program officer to discuss proposed research on SARS-CoV-2/COVID-2019. If it is within the scope of your current grant, an administrative supplement is the best option to obtain additional funding. PA-18-591
NIH/NIGMS: Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 https://grants.nih.gov/grants/guide/notice-files/NOT-GM-20-025.html
NIH/NIAID: Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease, https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-034.html
NIGMS Feedback Loop: https://loop.nigms.nih.gov/2020/03/urgent-competitive-revisions-to-nigms...
American Heart Association: Rapid Response Grants for Heart and Brain Focused Research related to COVID-19
NIH: NOT-AI-20-034 Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-1 https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-034.html
NIH: NOT-TR-20-011 Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-011.html
NIH PA-20-135 Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) https://grants.nih.gov/grants/guide/pa-files/PA-20-135.html
NIH NOT-EB-20-003 Notice of NIBIB's Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)" https://grants.nih.gov/grants/guide/notice-files/NOT-EB-20-003.html
NSF: On March 25, NSF released a Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19. NSF invites U.S.-based businesses to submit Phase I SBIR/STTR proposals focused on “the development and deployment of new technologies, products, processes, and services” that have the potential to help respond to COVID-19. The DCL highlights the following areas of research: artificial intelligence, digital health, diagnostics, distributed ledger, environmental technologies, medical devices, pharmaceutical technologies, disinfection and sterilization, and filtration and separations. The DCL is available at https://www.nsf.gov/pubs/2020/nsf20065/nsf20065.jsp?WT.mc_id=USNSF_25&WT.mc_ev=click
NIH/NIA/NIMH: Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) https://grants.nih.gov/grants/guide/notice-files/NOT-AG-20-022.html
Russel Sage Foundation: Funds to study social, political, economic, or psychological disruptions resulting from the coronavirus crisis that affect social and living conditions in the United States; https://www.russellsage.org/how-to-apply/application-deadlines
Sponsor Guidance for federal applicants and grantees:
DOJ: Sends you to CDC: https://www.coronavirus.gov/
OMB: Sends you to CDC; https://www.coronavirus.gov/